SCHEMBL12966550

SCHEMBL12966550

CN(C)N=Nc1ccc(C(=O)c2ccccc2OCCC(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.46
▸ MAPT P10636 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ DRD2 P14416 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ ABCB1 P08183 2/20 0.41
▸ SLC6A9 P48067 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ LTA4H P09960 2/20 0.38
▸ ELANE P08246 1/20 0.38
▸ PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12966651 0.87 RAB9A (0.53) MAPTRAB9ANPC1DRD2DRD1
SCHEMBL38663 0.82 PPARA (0.51) LMNAMAPTRAB9ANPC1L3MBTL1
SCHEMBL43048 0.82 PPARA (0.51) LMNAMAPTRAB9ANPC1L3MBTL1
SCHEMBL12966544 0.79 KMT2A (0.46) MAPTRAB9ANPC1KMT2AABCB1
SCHEMBL17988719 0.77 MAPT (0.45) LMNAMAPTRAB9ANPC1KMT2A
SCHEMBL12490357 0.76 STS (0.55) LMNAMAPTRAB9ANPC1ALDH1A1
SCHEMBL12966622 0.76 NPC1 (0.44) LMNAMAPTRAB9ANPC1KMT2A
SCHEMBL12966546 0.76 PPARA (0.57) LMNAMAPTRAB9ANPC1L3MBTL1
SCHEMBL12966653 0.75 MAPT (0.55) LMNAMAPTRAB9ANPC1KMT2A
SCHEMBL14699621 0.75 RAB9A (0.55) LMNAMAPTRAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130850-A1 TISSUE TARGETING BY MEANS OF ONCOCIDAL BRIDGED DIPHENYL DERIVATIVES FOR THE SELECTIVE TREATMENT OF SEXUAL ORGAN TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-04 — — WO disclosed
Send feedback